Navigation Links
Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
Date:10/24/2007

AIL receptors 1 and 2 offer a targeted mechanism of cancer-cell death that can be administered safely in combination with a variety of proven chemotherapies," said Gilles Gallant, B. Pharm., Ph.D., Vice President, Clinical Research - Oncology, HGS. "The data suggest that both pre-treatment and co-treatment with chemotherapy may be effective approaches to the use of TRAIL receptor antibodies for the treatment of cancer."

About the Results of the Phase 1b Trial of HGS-ETR2

In the first reported clinical trial of a TRAIL receptor 2 agonist in combination with chemotherapy, 41 patients with a wide range of solid malignancies received HGS-ETR2 plus a full-dose regimen of chemotherapy (gemcitabine, pemetrexed, doxorubicin or FOLFIRI). Four to seven patients in each chemotherapy cohort received HGS-ETR2 intravenously at doses of either 5 mg/kg or 10 mg/kg.

The results showed that HGS-ETR2 in combination with full-dose chemotherapy was generally safe and well tolerated. Objective responses were reported for two patients (a colorectal cancer patient in the FOLFIRI arm, and a small-cell lung cancer patient in the doxorubicin arm). Stable disease was observed in 22 patients. Overall, the nature and severity of adverse events were consistent with the underlying disease and known safety profile of the chemotherapeutic regimens. The pharmacokinetics of HGS-ETR2 were not influenced by the chemotherapeutic agents, nor did HGS-ETR2 affect the pharmacokinetics of gemcitabine, doxorubicin or irinotecan. Further studies of HGS-ETR2 in combination with chemotherapy are warranted.

"The results of the Phase 1b study of HGS-ETR2 show that it is well tolerated and can be repetitively administered in combination with standard chemotherapy agents in patients with a variety of advanced solid malignances," said Norma Lynn Fox, Ph.D., Senior Director, Clinical Research, HGS. "We were encouraged by the observation of objective responses in two patients and stable disease i
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Medical researchers with EDP Biotech Corporation (EDP) ... technology for a simple blood test to detect ... success of its pre-clinical trials for the ColoMarker(TM) ... biomarker, CA11-19, and all aspects of its use. ... detect colon cancer in its earliest, most curable ...
(Date:12/15/2009)... Dec. 15 Certified healthcare providers who ... complications from the H1N1 flu virus may now ... the Department of Health announced today. ,, ... everyone because approximately 3.2 million doses of vaccine ... it to individuals in the priority groups. ,, ...
(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...
Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Are the monoamines involved in shaping conduct disorders 3F 9898 1Are the monoamines involved in shaping conduct disorders 3F 9898 2Are the monoamines involved in shaping conduct disorders 3F 9898 3Are the monoamines involved in shaping conduct disorders 3F 9898 4Are the monoamines involved in shaping conduct disorders 3F 9898 5Are the monoamines involved in shaping conduct disorders 3F 9898 6Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 1Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 2Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 3Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 4For Organ Donation Intent and Reality Dont Align 56981 1For Organ Donation Intent and Reality Dont Align 56981 2For Organ Donation Intent and Reality Dont Align 56981 3
... Menopause Society 19th Annual ... Meeting, ... present an abstract in a presentation on their new drug,candidate, VG101, for ... American Menopause Society in Orlando, Florida on,September 26, 2008. Dr. Mary Tagliaferri, ...
... LAUSANNE, Switzerland, September 25 Debiopharm Group,(Debiopharm), ... serious medical conditions and particularly oncology, announces,the ... Agencies for the approval of,its new 6-month ... luteinizing hormone releasing hormone (LHRH) agonist for ...
Other Medicine Technology:Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 2Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 3Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients 2
(Date:12/15/2009)... Authority, Ban on Annual Benefit Limits, & Effective ... -- Consumer Watchdog condemned the removal of the ... the public option from the U.S. Senate health ... Senate must still make three essential fixes to ... entire health care system to the insurance industry. ...
(Date:12/15/2009)... Palo Alto Networks(TM), the network security company, today ... Series next-generation firewalls for accurate threat prevention on ... control over applications such as peer-to-peer file sharing. ... with eight facilities on five campuses. The university ... of academic schools and institutions throughout Japan. It ...
(Date:12/15/2009)... Dec. 15 Our Lady of Lourdes Health ... Jersey hospitals, has agreed to pay the United States ... Medicare, the Justice Department announced today. The two hospitals ... Camden, N.J., and Lourdes Medical Center of Burlington County ... defendant in a suit brought by a whistleblower, Tony ...
(Date:12/15/2009)... risk, research finds , , TUESDAY, Dec. 15 (HealthDay News) ... regulates appetite, may guard against Alzheimer,s disease, new research ... may be one of many agents that we use ... study author Dr. Sudha Seshadri, an associate professor of ... may be one of many markers that we measure ...
(Date:12/15/2009)... CDC have released some sobering statistics concerning the parallel rise in ... employers an effective means of combating this trend afflicting their workforce. ... ... Rates of diabetes are climbing across America due in large part ... the American Diabetes Association has stated that the rate of diabetes ...
Breaking Medicine News(10 mins):Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3
... Pharmaceutical product teams,have the power to make ... The problem is,launch teams often lack the right ... only produce a sub-optimal launch. In fact, ... and cross-functional team work are key ingredients,during product ...
... Advancement of Novel Technology and ... Product Portfolio, ... therapeutic antibody product company, today announced that,it has raised $33.9 million ... participating significantly in the round were Frazier,Healthcare Ventures and Alloy Ventures, ...
... CHICO, Calif., Nov. 8 State,Compensation Insurance Fund ... part of State Fund,s Employer Education Series, featuring ... Back,Connection(TM). The three-hour seminar entitled "Watch Your Back",introduces ... how they,can involve the very people they are ...
... InteKrin Therapeutics, Inc.,a privately-held clinical stage biopharmaceutical ... drugs for the treatment of,diabetes and cardio-metabolic diseases, ... the company as Chief Medical Officer. Dr. DePaoli,will ... and will be,responsible for the clinical development of ...
... $7.5 Million in 2008, OTTAWA, Canada, ... Natural Nutrition press release is, http://www.naturalnutritioninc.com . ... (OTC Bulletin Board: NNTN), http://www.naturalnutritioninc.com has ... adding state-of-the-art equipment to produce,sheeted protein and ...
... On November 9, the,Department of Veterans Affairs ... award one contract to conduct two important technical ... the updating of our military,disability system. The studies ... on Care for America,s Returning Wounded Warriors,co-chaired by ...
Other Medicine News:Health News:Pharmaceutical Product Commercialization: Enabling Teams to Excel 2Health News:Pharmaceutical Product Commercialization: Enabling Teams to Excel 3Health News:Anaptys Biosciences Raises Over $33 Million in Series B Financing 2Health News:Anaptys Biosciences Raises Over $33 Million in Series B Financing 3Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 2Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 3Health News:InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer 2Health News:InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer 3Health News:Corrected & Replaced - Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line 2Health News:Modernizing and Improving the Disability and Compensation Systems 2Health News:Modernizing and Improving the Disability and Compensation Systems 3
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....
Skull Traction Tongs for cervical vertebra extension, adjustable pins, eliminates need for preliminary drilling, large pattern, complete with wrench...
Cushing Flat Drill, only Component Parts and Accessories for HUDSON Cranial Drill. 14 mm...
Medicine Products: